ArticleDrug design, development and therapy2018

Comparison of the efficacy and survival analysis of neoadjuvant chemotherapy for Her-2-positive breast cancer.

Si Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.